Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€8.80

€8.80

-1.080%
-0.1
-1.080%
€16.00
 
27.03.24 / Tradegate WKN: A143XJ / Name: Voyager / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Voyager Therapeutics Inc Stock

We can see a decrease in the price for Voyager Therapeutics Inc. Compared to yesterday it has lost -€0.100 (-1.080%).
Currently there is a rather positive sentiment for Voyager Therapeutics Inc with 3 Buy predictions and 0 Sell predictions.
With a target price of 16 € there is a hugely positive potential of 81.82% for Voyager Therapeutics Inc compared to the current price of 8.8 €.
Our community identified positive and negative aspects for Voyager Therapeutics Inc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Voyager Therapeutics Inc stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of Voyager Therapeutics Inc in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Voyager Therapeutics Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Voyager Therapeutics Inc -1.080% 1.149% 6.024% 29.450% 10.692% 114.634% -
Salarius Pharmaceuticals Inc. 1.470% -18.824% -22.617% -76.389% -25.405% -98.665% -99.992%
Ardelyx Inc. -1.160% -6.371% -22.654% 73.980% 16.955% 25.791% -
Evolus Inc -0.770% 2.362% -2.985% 66.667% 39.037% 31.287% -

News

Voyager Therapeutics stock pops 30% on deal with Novartis: https://www.marketbeat.com/logos/articles/med_20240108080612_voyager-therapeutics-pops-30-on-gene-therapy-deal.jpg
Voyager Therapeutics stock pops 30% on deal with Novartis

Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took a 30% spike on news of its partnership with